Shield signs licence to market rheumatoid arthritis test
This article was originally published in Clinica
Executive Summary
Shield Diagnostics has moved into the rheumatoid arthritis diagnosis and monitoring market through a licensing agreement with a Dutch consortium for the rights to a test for early diagnosis of the condition. The deal with the University of Nijmegen and technology foundation STW covers all countries outside of Europe.